novo nordisk weight loss drug - Search News

News

Medicaid, weight loss

MarketWatch on MSN · 35m

Weight-loss drugs may be coming to Medicare, Medicaid under experimental program

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a diagnosis of diabetes or cardiovascular disease and who have obesity or who are overweight, but not for the treatment of obesity itself.

Reuters on MSN · 7h

US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and Medicaid Services.

The Independent on MSN · 9h

All the health conditions weight-loss drugs are being used and tested for

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some success

2hon MSN

Eli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk.

Eli Lilly’s best-selling diabetes drug Mounjaro lowered the risk of heart attacks and stroke in a late-stage trial, the ...

4hon MSN

Novo Nordisk shares extend losses, erasing nearly all gains since Wegovy launch

Shares in Novo Nordisk fell as much as six per cent on Friday to their lowest since August 2021, extending recent losses to ...

1don MSN

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

Danish leader will face a challenging landscape among competitors ...

3hon MSN

Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Revenue Windfall Expected As Dr Reddy’s Lab Gears Up To Launch Generic Obesity Drug

HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable ...

5hon MSN

Novo Nordisk shares dip further as Wegovy gains nearly erased

Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent ...

3don MSN

Novo Nordisk shares plummet over 20% on weight-loss drug sale slump

The firm also named Maziar Mike Doustdar as its new CEO on Tuesday, after a gloomy financial forecast spooked investors.View ...

Novo Nordisk Announces New CEO Amidst Weight-Loss Drug Competition

Novo Nordisk appoints Maziar Mike Doustdar as the new CEO to tackle falling sales and shares amid stiff competition in the ...

21hon MSN

Why Novo Nordisk Stock Crumbled Again Today

That pundit was HSBC's Rajesh Kumar, who downgraded his recommendation on Novo Nordisk that morning. Image source: . Kumar ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results